Atyr Pharma Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on August 9, 2018, by Atyr Pharma, Inc. (Nasdaq: LIFE). The filing primarily addresses a notice of potential delisting due to stock price deficiencies and references the company's financial results for the quarter ended June 30, 2018, which were announced on August 14, 2018.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the earnings press release attached as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes and Listing Status
On August 9, 2018, the Company received a notice from The Nasdaq Stock Market stating that its common stock had closed below the $1.00 per share minimum bid price requirement for 30 consecutive trading days. This triggers a compliance period under Nasdaq Listing Rule 5810(c)(3)(A).
- Compliance Deadline: February 5, 2019 (180 calendar days from the notice).
- Requirement: The closing bid price must be at or above $1.00 for a minimum of 10 consecutive business days within the compliance period.
- Current Status: The stock continues to trade on The Nasdaq Global Market under the symbol "LIFE" pending compliance.
Outlook, Risks, and Management Commentary
Management intends to monitor the closing bid price and may consider available options to regain compliance, including a potential transfer to The Nasdaq Capital Market. If the Company transfers to the Capital Market, it may qualify for an additional 180-day compliance period, potentially involving a reverse stock split.
Risks: The Company explicitly states it cannot provide assurances that it will be able to regain compliance, even if it transfers to the Nasdaq Capital Market. Failure to cure the deficiency could result in delisting.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended June 30, 2018, by reviewing Exhibit 99.1 (Earnings Press Release) as the 8-K text does not contain these figures.
- Monitor the daily closing bid price of the stock to determine if it meets the $1.00 threshold for 10 consecutive days before February 5, 2019.
- Watch for announcements regarding a potential reverse stock split or application to transfer listing to The Nasdaq Capital Market.
- Confirm the continued trading status of the stock on Nasdaq to ensure no immediate delisting action has been taken.